A study of Eflapegrastim in the Management of Chemotherapy-Induced Neutropenia in Breast Cancer Patients
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Eflapegrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- 17 Nov 2016 New trial record